Methotrexate could benefit patients with chronic arthritis following chikungunya virus infection, according to the findings of a systematic review. The analysis included four retrospective studies, one prospective study and one non-blinded randomized clinical trial that evaluated methotrexate either as monotherapy or in combination with other treatments, highlighting the need for large-scale, carefully conducted studies, particularly blinded, randomized clinical trials.